Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine.
Schuld
A
A
Kraus
T
T
Haack
M
M
Hinze-Selch
D
D
Kühn
M
M
Pollmächer
T
T
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018121:Receptors, Cytokine / Q000097:blood / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy* / Q000276:immunology
D014150:Antipsychotic Agents; D016207:Cytokines; D018121:Receptors, Cytokine; D001569:Benzodiazepines; D010890:Pirenzepine; D003024:Clozapine; D000077152:Olanzapine